Nuvation Bio's Lung Cancer Drug Accepted for Review in Europe-March 2024-www.financetom.com

Nuvation Bio's Lung Cancer Drug Accepted for Review in Europe

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Nuvation Bio's Lung Cancer Drug Accepted for Review in Europe

Mar 26, 2026 3:13 PM

05:32 PM EDT, 03/26/2026 (MT Newswires) -- Nuvation Bio ( NUVB ) and Eisai said Thursday that the European Medicines Agency validated the marketing authorization application for taletrectinib, an oral treatment for advanced ROS1-positive non-small cell lung cancer.

The application has been accepted for full approval consideration under a standard review timeline.

Additional regulatory filings are planned in the UK, Canada and other licensed territories.

Previous page： Jacobs Solutions Hits Some Bumps Despite Q2 Beat, Narrows Outlook Next page： Tesla Chair Sells $17.3 Million Worth of Company Shares

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Jacobs Solutions Hits Some Bumps Despite Q2 Beat, Narrows Outlook

May 7, 2024

Jacobs Solutions Inc. ( J ) shares are trading lower after it reported second-quarter FY24 results. Revenue grew 4.7% Y/Y to $4.27 billion, beating the consensus of $3.98 billion. Adjusted EPS totaled $1.91, beating the consensus of $1.85. The backlog in the quarter under review was $29.4 billion, up 1.5% Y/Y. Gross profit in backlog was up 3.7% Y/Y. The company registered cash flow from operations of $376 million in the six months of FY24. The company bought back...

Tesla Chair Sells $17.3 Million Worth of Company Shares

May 7, 2024

10:45 AM EDT, 05/07/2024 (MT Newswires) -- Tesla (TSLA) Chair Robyn Denholm sold 93,705 company shares with an aggregate market value of $17.3 million, according to a Monday filing. Price: 179.46, Change: -5.30, Percent Change: -2.87 ...

Wozniak's space firm, Privateer, buys Orbital Insight, raises $56.5 million

May 7, 2024

(This May 6 story has been corrected to fix the spelling of BOKA Group and Lux Capital in paragraph 2) By Joey Roulette WASHINGTON (Reuters) - Apple cofounder Steve Wozniak's space data startup, Privateer, has raised $56.5 million and also acquired the analytics firm Orbital Insight, a merger that will add mapping and intelligence services to Privateer's space data offerings,...

Akamai Technologies to Buy Noname Security for $450 Million

May 7, 2024

10:47 AM EDT, 05/07/2024 (MT Newswires) -- Akamai Technologies ( AKAM ) agreed to buy Noname Security for $450 million to bolster API security offerings. Oz Golan, Noname's co-founder and chief executive officer, and 200 employees are expected to join Akamai's ( AKAM ) security technology group. The deal is expected to close in Q2, Akamai ( AKAM ) said...